Huntington National Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.04K Hold
876
﹤0.01% 1961
2025
Q4
$15.1K Hold
876
﹤0.01% 1683
2025
Q3
$22.6K Hold
876
﹤0.01% 1563
2025
Q2
$50.4K Hold
876
﹤0.01% 1238
2025
Q1
$94.8K Hold
876
﹤0.01% 936
2024
Q4
$41.6K Buy
+876
New +$53K ﹤0.01% 1286
2024
Q1
Sell
-43
Closed -$13.4K 3964
2023
Q4
$13.4K Hold
43
﹤0.01% 1544
2023
Q3
$19K Sell
43
-17
-28% -$7.68K ﹤0.01% 1366
2023
Q2
$26.2K Buy
60
+42
+233% +$23.6K ﹤0.01% 1277
2023
Q1
$10.5K Hold
18
﹤0.01% 1515
2022
Q4
$7.15K Buy
+18
New +$8.44K ﹤0.01% 1562

Other funds holding AGL

Huntington National Bank's AGL Position: Q1 2026 in Review

Huntington National Bank held its Agilon Health (AGL) position steady in Q1 2026 at 876 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

Huntington National Bank first reported a position in AGL in Q4 2022 and has held it in 11 quarters since. The position peaked at $94.8K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Huntington National Bank held 876 shares of Agilon Health worth $7.04K as of Q1 2026.
  • Huntington National Bank left its Agilon Health share count unchanged in Q1 2026.
  • Agilon Health made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1961 holding.
  • Huntington National Bank first reported a position in Agilon Health in Q4 2022 and has held it in 11 quarters since.
  • Huntington National Bank's Agilon Health position peaked at $94.8K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.